AI Drug Discovery: SandboxAQ, Tazbentetol, and New
SandboxAQ integrated its physics-grounded drug discovery models into Anthropic's Claude this week, while schizophrenia drug tazbentetol…
SandboxAQ integrated its physics-grounded drug discovery models into Anthropic's Claude this week, while schizophrenia drug tazbentetol…
SandboxAQ has integrated physics-based molecular models into Anthropic's Claude, lowering the barrier to AI-assisted drug discovery.…
Isomorphic Labs raised $2.1 billion for AI drug discovery on May 13, 2026, while hospitals face…
Isomorphic Labs raised a record $2.1 billion for AI drug discovery while healthcare AI deployments face…
Isomorphic Labs raised $2.1 billion in the second-largest biotech funding round ever, using Nobel Prize-winning AlphaFold…
Isomorphic Labs raised $2.1 billion for AI drug discovery while hospitals face deployment challenges with AI…
Isomorphic Labs raised $2.1 billion for AI drug discovery while hospitals deploy AI agents for medical…
Isomorphic Labs raised $2.1 billion for AI drug discovery while hospital AI deployments face identity management…
IBM's MAMMAL model outperforms AlphaFold 3 on 9 biological benchmarks through multi-modal data integration, while autonomous…
IBM Research's MAMMAL multimodal AI model achieved state-of-the-art performance on 9 out of 11 biological benchmarks,…
IBM's MAMMAL multimodal AI model outperformed AlphaFold 3 on 9 out of 11 biological benchmarks by…
IBM's new MAMMAL model outperformed AlphaFold 3 on 9 of 11 biological benchmarks by combining protein,…